Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash.
Salix Pharmaceuticals SLXP had $817.98 million in total cash and $875.74 million in total debt for the latest quarter.
Mylan MYL had $360.07 million in total cash for the latest quarter. However, Mylan had $6.22 billion in total debt for the same period.
Hi-Tech Pharmacal Co HITK had $108.28 million in total cash and $1.15 million in total debt for the latest quarter.
Akorn AKRX had $58.41 million in total cash and $106.66 million in total debt for the latest quarter.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in